Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYMEWORKS INC (US)

12.60
+0.47003.87%
Post-market: 12.600.00000.00%16:35 EDT
Volume:362.35K
Turnover:4.56M
Market Cap:878.01M
PE:-8.38
High:12.75
Open:12.33
Low:12.33
Close:12.13
Loading ...

Zymeworks Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Mar

Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
06 Mar

Stock Track | Zymeworks Plunges 5.46% After-Hours on Wider Q4 Loss and Missed Revenue Estimates

Stock Track
·
06 Mar

Zymeworks Q4 Net Loss Widens, Revenue Increases; Shares Fall After Hours

MT Newswires Live
·
06 Mar

Zymeworks Q4 GAAP EPS $(0.31) Misses $(0.03) Estimate, Sales $31.03M Miss $45.20M Estimate

Benzinga
·
06 Mar

BRIEF-Zymeworks Q4 Pretax Profit USD -17.791 Million

Reuters
·
06 Mar

Zymeworks Q4 Pretax Profit USD -17.791 Million

THOMSON REUTERS
·
06 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 Mar

Zymeworks Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
04 Mar

Zymeworks Achieves $14 Million in Milestone Payment From GSK Partnership

MT Newswires Live
·
26 Feb

Zymeworks Announces Achievement of $14 Million Milestone From GSK Collaboration

THOMSON REUTERS
·
26 Feb

Press Release: Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration

Dow Jones
·
26 Feb

Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire
·
25 Feb

Pitney Bowes, Nathan's, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
22 Feb

Zymeworks appoints Oleg Nodelman to Board

TIPRANKS
·
18 Feb

BRIEF-Zymeworks Announces Appointment Of Oleg Nodelman To Board Of Directors

Reuters
·
18 Feb

Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors

THOMSON REUTERS
·
18 Feb

Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors

GlobeNewswire
·
18 Feb

The past five years for Zymeworks (NASDAQ:ZYME) investors has not been profitable

Simply Wall St.
·
23 Jan

Big Biotech Fund Bought a Stock That Surged, and a Loser -- Barron's

Dow Jones
·
18 Jan